Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
2.040
-0.010 (-0.49%)
At close: Nov 21, 2024, 4:00 PM
2.080
+0.040 (1.96%)
After-hours: Nov 21, 2024, 5:20 PM EST
RANI Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 4.28 | 5.86 | 27.01 | 117.45 | 73.06 | 16.54 |
Short-Term Investments | 26.13 | 42.68 | 71.48 | - | - | - |
Cash & Short-Term Investments | 30.4 | 48.54 | 98.48 | 117.45 | 73.06 | 16.54 |
Cash Growth | -49.77% | -50.71% | -16.15% | 60.77% | 341.81% | - |
Other Receivables | - | 0.2 | - | - | - | - |
Receivables | - | 0.2 | - | - | 1.72 | 0.25 |
Prepaid Expenses | 1.97 | 1.31 | 1.94 | 2.14 | 0.17 | 0.16 |
Restricted Cash | - | 0.5 | 0.5 | - | - | - |
Other Current Assets | - | 0.3 | - | - | - | - |
Total Current Assets | 32.37 | 50.85 | 100.92 | 119.6 | 74.95 | 16.94 |
Property, Plant & Equipment | 10.92 | 6.82 | 7.1 | 4.61 | 4.47 | 4.45 |
Other Long-Term Assets | 0.25 | 0.25 | - | - | - | - |
Total Assets | 43.54 | 57.92 | 108.03 | 124.21 | 79.42 | 23.02 |
Accounts Payable | 1.57 | 0.65 | 1.46 | 1.08 | 0.54 | 0.2 |
Accrued Expenses | 1.87 | 1.47 | 1.76 | 1.43 | 0.55 | 0.6 |
Current Portion of Long-Term Debt | 14.77 | 4.9 | - | - | 1.36 | - |
Current Portion of Leases | 1.41 | 0.72 | 1.01 | - | - | - |
Current Unearned Revenue | 0.6 | - | - | - | 2.72 | 0.18 |
Other Current Liabilities | - | 0.25 | 0.59 | 0.13 | 0.15 | 2.52 |
Total Current Liabilities | 20.21 | 7.99 | 4.82 | 2.64 | 5.31 | 3.5 |
Long-Term Debt | 13.54 | 24.48 | 29.15 | - | 2.41 | - |
Long-Term Leases | 4.02 | - | 0.06 | - | - | - |
Total Liabilities | 37.77 | 32.47 | 34.02 | 2.64 | 7.72 | 3.5 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.66 | 0.66 |
Additional Paid-In Capital | 97.07 | 85.76 | 75.84 | 55.74 | - | - |
Retained Earnings | -93.96 | -72.89 | -38.92 | -8.33 | -114 | -97.3 |
Comprehensive Income & Other | 0.01 | -0.01 | -0.07 | - | - | - |
Total Common Equity | 3.12 | 12.87 | 36.86 | 47.41 | -113.34 | -96.64 |
Minority Interest | 2.66 | 12.58 | 37.15 | 74.16 | - | - |
Shareholders' Equity | 5.78 | 25.44 | 74 | 121.57 | 71.7 | 19.52 |
Total Liabilities & Equity | 43.54 | 57.92 | 108.03 | 124.21 | 79.42 | 23.02 |
Total Debt | 33.73 | 30.1 | 30.21 | - | 3.77 | - |
Net Cash (Debt) | -3.33 | 18.44 | 68.27 | 117.45 | 69.29 | 16.54 |
Net Cash Growth | - | -72.99% | -41.88% | 69.52% | 319.01% | - |
Net Cash Per Share | -0.12 | 0.72 | 2.87 | 6.01 | 1.48 | 0.35 |
Filing Date Shares Outstanding | 33.31 | 26.04 | 25.3 | 24.39 | 46.9 | 46.89 |
Total Common Shares Outstanding | 29.81 | 26.04 | 25.3 | 19.71 | 46.89 | 46.89 |
Working Capital | 12.16 | 42.86 | 96.11 | 116.96 | 69.64 | 13.45 |
Book Value Per Share | 0.10 | 0.49 | 1.46 | 2.41 | -2.42 | -2.06 |
Tangible Book Value | 3.12 | 12.87 | 36.86 | 47.41 | -113.34 | -96.64 |
Tangible Book Value Per Share | 0.10 | 0.49 | 1.46 | 2.41 | -2.42 | -2.06 |
Machinery | - | 4.18 | 2.82 | 1.78 | 1.64 | 1.4 |
Construction In Progress | - | 3.9 | 4.42 | 3.87 | 3.48 | 3.22 |
Leasehold Improvements | - | 1.59 | 1.55 | 1.23 | 1.12 | 1.02 |
Source: S&P Capital IQ. Standard template. Financial Sources.